Improving Services for HIV-Exposed Infants in Zambia and Cameroon Using a Quality Improvement Collaborative Approach.


Journal

Global health, science and practice
ISSN: 2169-575X
Titre abrégé: Glob Health Sci Pract
Pays: United States
ID NLM: 101624414

Informations de publication

Date de publication:
30 06 2021
Historique:
received: 03 09 2020
accepted: 06 04 2021
entrez: 8 7 2021
pubmed: 9 7 2021
medline: 18 11 2021
Statut: epublish

Résumé

Early infant diagnosis (EID) and rapid antiretroviral therapy (ART) initiation are lifesaving interventions for HIV-infected infants. In Cameroon and Zambia, EID coverage for HIV-exposed infants (HEIs) is suboptimal and the time to ART initiation for infants infected with HIV often exceeds national standards despite numerous policy and training initiatives. ICAP at Columbia University supported the Cameroon and Zambia Ministries of Health (MOHs) and local partners to implement quality improvement collaboratives (QICs) to improve EID coverage and ART initiation at 17 health facilities (HFs) in Cameroon (March 2016 to June 2017) and 15 HFs in Zambia (March 2017 to June 2018). In each country, MOH led project design and site selection. MOH and ICAP provided quality improvement training and monthly supportive supervision, which enabled HF teams to conduct root cause analyses, design and implement contextually appropriate interventions, conduct rapid tests of change, analyze monthly progress, and convene at quarterly learning sessions to compare performance and share best practices. In Cameroon, EID testing coverage improved from 57% (113/197 HEIs tested) during the 5-month baseline period to 80% (165/207) in the 5-month endline period. In Zambia, EID testing coverage improved from 77% (4,773/6,197) during the 12-month baseline period to 89% (2,144/2,420) during the 3-month endline period. In a comparison of the same baseline and endline periods, the return of positive test results to caregivers improved from 18% (36/196 caregivers notified) to 86% (182/211) in Cameroon and from 44% (94/214) to 79% (44/56) in Zambia. ART initiation improved from 44% (94/214 HIV-infected infants) to 80% (45/56) in Zambia; the numbers of HIV-infected infants in Cameroon were too small to detect meaningful differences. QICs improved coverage of timely EID and ART initiation in both countries. In addition to building quality improvement capacity and improving outcomes, the QICs resulted in a "change package" of successful initiatives that were disseminated within each country.

Identifiants

pubmed: 34234027
pii: GHSP-D-20-00550
doi: 10.9745/GHSP-D-20-00550
pmc: PMC8324201
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

399-411

Subventions

Organisme : PEPFAR
ID : 1U1NHA285550100
Pays : United States

Informations de copyright

© Dougherty et al.

Références

J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):487-496
pubmed: 31149954
J Int AIDS Soc. 2014 Jun 11;17:18914
pubmed: 24925044
BMJ Qual Saf. 2014 Apr;23(4):290-8
pubmed: 24025320
J Acquir Immune Defic Syndr. 2015 Mar 1;68(3):e26-32
pubmed: 25469521
BMJ Qual Saf. 2011 Aug;20(8):658-65
pubmed: 21317182
BMJ. 2008 Jun 28;336(7659):1491-4
pubmed: 18577559
BMJ Qual Saf. 2011 Apr;20 Suppl 1:i36-40
pubmed: 21450768
Int J Qual Health Care. 2002 Dec;14 Suppl 1:89-95
pubmed: 12572792
BMJ Qual Saf. 2016 Mar;25(3):147-52
pubmed: 26700542
Lancet Glob Health. 2018 Nov;6(11):e1196-e1252
pubmed: 30196093
J Assoc Nurses AIDS Care. 2019 Nov-Dec;30(6):682-690
pubmed: 30817370
BMJ Qual Saf. 2014 Apr;23(4):265-7
pubmed: 24365606
Lancet Glob Health. 2016 Sep;4(9):e594-6
pubmed: 27539798
BMJ Qual Saf. 2011 Jan;20(1):46-51
pubmed: 21228075
Qual Saf Health Care. 2005 Apr;14(2):140-3
pubmed: 15805461
BMJ Qual Saf. 2017 Jul;26(7):572-577
pubmed: 27986900
Pan Afr Med J. 2013 Jun 21;15:65
pubmed: 24198870
Qual Saf Health Care. 2007 Feb;16(1):77-80
pubmed: 17301211
BMJ Qual Saf. 2016 May;25(5):345-54
pubmed: 26208537
J Assoc Nurses AIDS Care. 2018 Sep - Oct;29(5):785-794
pubmed: 29803605
Int J Qual Health Care. 2014 Apr;26(2):117-23
pubmed: 24481053
J Acquir Immune Defic Syndr. 2017 May 1;75 Suppl 1:S51-S58
pubmed: 28398997
J Acquir Immune Defic Syndr. 2015 Jan 1;68(1):62-72
pubmed: 25501345

Auteurs

Gillian Dougherty (G)

ICAP at Columbia University, Columbia University Mailman School of Public Health, New York, NY, USA. gd2410@columbia.edu.

Tihnje Abena (T)

ICAP at Columbia University, Yaoundé, Cameroon.

Jean Pierre Abesselo (JP)

ICAP at Columbia University, Yaoundé, Cameroon.

Jeane Ngala Banda (JN)

Ministry of Health, Lusaka, Zambia.

Tjek Paul Biyaga (TP)

Ministry of Health, Yaoundé, Cameroon.

Rodrigo Boccanera (R)

Health Resources and Services Administration, Rockville, MD, USA.

Mary Adetinuke Boyd (MA)

Centers for Disease Control and Prevention, Lusaka, Zambia.

Mesmey Ebogo (M)

ICAP at Columbia University, Yaoundé, Cameroon.

Leoda Hamomba (L)

Centers for Disease Control and Prevention, Lusaka, Zambia.

Suzanne Jed (S)

Health Resources and Services Administration, Rockville, MD, USA.

Zeh Florence Kakanou (ZF)

Ministry of Health, Yaoundé, Cameroon.

Prisca Kasonde (P)

ICAP at Columbia University, Lusaka, Zambia.

Siphiwe Chilungu Kasonka (SC)

ICAP at Columbia University, Lusaka, Zambia.

Rachael Lungwebungu (R)

Ministry of Health, Lusaka, Zambia.

Caitlin Madevu-Matson (C)

ICAP at Columbia University, Columbia University Mailman School of Public Health, New York, NY, USA.

Magdalene Mange Mayer (MM)

Centers for Disease Control and Prevention, Yaoundé, Cameroon.

Mukuka Mwamba (M)

ICAP at Columbia University, Lusaka, Zambia.

Milembe Panya (M)

ICAP at Columbia University, Dar es Salaam, Tanzania.

Paul Sakanda (P)

ICAP at Columbia University, Lusaka, Zambia.

Fatima Tsiouris (F)

ICAP at Columbia University, Columbia University Mailman School of Public Health, New York, NY, USA.

Lauren Walker (L)

ICAP at Columbia University, Columbia University Mailman School of Public Health, New York, NY, USA.

Miriam Rabkin (M)

ICAP at Columbia University, Columbia University Mailman School of Public Health, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH